Florida Gov. Ron DeSantis has spent two months cross-crossing the state promoting sites and clinics that offer monoclonal antibody treatments, an increasingly popular alternative to vaccines for protection from COVID-19.
In fact, so popular that last week, the U.S. Department of Health & Human Services (DHS), while increasing overall supplies by 50%, from 100,000 to 150,000 doses a week nationwide, but capping the number of doses being delivered to Florida and six other Southern states that had previously consumed more than 70% of the nation’s monoclonal antibody treatments.
Thursday morning on the Tennessee Star Report, host Michael Patrick Leahy welcomed all-star panelist Roger Simon in studio to weigh in on the distribution of monoclonal antibody treatments and free-market pharmaceutical companies.
Florida Governor Ron DeSantis announced on Thursday that the state of Florida purchased thousands of monoclonal antibody treatments directly from GlaxoSmithKline, a producer of the treatment.
The move by DeSantis bypasses a restriction placed by President Joe Biden’s administration, allowing the federal government to dictate allocations to each state and leave it to state leaders to ration it out among locations.